Search company, investor...
Vocalis Health company logo

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

Founded Year



Incubator/Accelerator | Alive

Total Raised


About Vocalis Health

Vocalis Health is a vocal biomarker company that uses voice to detect, diagnose, and monitor patient health.

Vocalis Health Headquarters Location

275 Grove Street Suite 2-400

Newton, Massachusetts, 02466,

United States

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Research containing Vocalis Health

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned Vocalis Health in 4 CB Insights research briefs, most recently on Oct 7, 2021.

Expert Collections containing Vocalis Health

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Vocalis Health is included in 11 Expert Collections, including Digital Health.


Digital Health

21,952 items

Startups recreating how healthcare is delivered


Mental Health Tech

1,246 items

This collection includes companies applying technology to problems of emotional, psychological, and social well-being. Examples include companies working in areas such as substance abuse, eating disorders, stress reduction, depression, PTSD, and anxiety.


Artificial Intelligence

9,391 items

This collection includes startups selling AI SaaS, using AI algorithms to develop their core products, and those developing hardware to support AI workloads.


Medical Devices

8,487 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.


Biopharma Tech

5,241 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.


Conference Exhibitors

5,302 items

Vocalis Health Patents

Vocalis Health has filed 3 patents.

The 3 most popular patent topics include:

  • Machine learning
  • Artificial intelligence
  • Artificial neural networks
patents chart

Application Date

Grant Date


Related Topics




Phonetics, Auditory system, Speech recognition, Speech codecs, Computational linguistics


Application Date


Grant Date



Related Topics

Phonetics, Auditory system, Speech recognition, Speech codecs, Computational linguistics



Latest Vocalis Health News

‘Voice biomarker’ may predict chest pain, ACS, coronary artery disease

Apr 3, 2022

Source: Sara JDS, et al. Abstract 1319-121. Presented at: American College of Cardiology Scientific Session; April 2-4, 2022; Washington, D.C. (hybrid meeting). Disclosures: One author reports consulting for Vocalis Health. Lerman and the other authors report no relevant financial disclosures. ADD TOPIC TO EMAIL ALERTS Receive an email when new articles are posted on Please provide your email address to receive an email when new articles are posted on . Subscribe ADDED TO EMAIL ALERTS Back to Healio We were unable to process your request. Please try again later. If you continue to have this issue please contact . Back to Healio WASHINGTON — A “voice biomarker” may be able to predict which patients have CAD or develop chest pain or ACS, according to findings presented at the American College of Cardiology Scientific Session. For 108 patients (mean age, 59 years; 55% men; 57% with stable angina) clinically indicated for coronary angiography, researchers used an app (Vocalis Health) to make three 30-second voice recordings to establish a voice biomarker score, and calculated a voice biomarker value for each patient. Amir Lerman, MD, professor of medicine, consultant in the department of cardiovascular medicine, and director of the Chest Pain and Coronary Physiology Clinic at Mayo Clinic in Rochester, Minnesota. “This is not speech. This is the frequency of the voice that someone uses, like the frequency of an electrocardiogram,” Amir Lerman, MD, professor of medicine, consultant in the department of cardiovascular medicine, and director of the Chest Pain and Coronary Physiology Clinic at Mayo Clinic in Rochester, Minnesota, told Healio. “It’s just about the frequency that changes when you make sounds. We are able to analyze the domain of the frequencies.” The researchers analyzed the relationship between voice biomarker score and the primary outcome of presenting to the ED with chest pain , being admitted for chest pain or having ACS, and the secondary outcome of a positive stress test result or the presence of CAD at follow-up angiography. Median follow-up was 24 months. The findings were simultaneously published in Mayo Clinic Proceedings. “Several years ago, we got interested in the use of voice as a biomarker for identifying disease,” Lerman told Healio. “Because we are cardiologists, we wanted to see if it was related to coronary disease. Our first study showed that there are special domains in the voice that are characteristic of coronary disease. Our interest for this study was to see if that predicted events in coronary disease. As a physician, you do pay attention if a patient’s voice is different, even if it has not been an exact science.” Patients were stratified by whether they had a high voice biomarker, defined as greater than 0.5217. The median voice biomarker level was 0.0675. In a multivariable analysis adjusted for CAD grade on baseline angiography, patients who had a high voice biomarker level had elevated risk for the primary outcome (adjusted HR = 2.61; 95% CI, 1.42-4.8; P = .002) and the secondary outcome (aHR = 3.13; 95% CI, 1.13-8.68; P = .03) compared with those who did not, according to the researchers. “The study showed that voice can be a noninvasive biomarker of disease, especially in these days of trying to collect data from the patient without the patient coming to the facility,” Lerman told Healio. “This information can be collected over the phone. Another message is that disease affects the body in different ways. If you have heart disease, it may not just be indicated by abnormalities in the heart. It can have a systemic effect.” More research must be done before voice biomarkers can be used in clinical practice, Lerman told Healio. “We need larger and different populations to prove the concept beyond patients who come to Mayo Clinic,” he said. “One prior study showed that this is not language-dependent, which is important. But we need to show it works in other communities and populations. There is a signal, but we need to get more work done.” Reference:

Vocalis Health Web Traffic

Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Vocalis Health Rank

  • When was Vocalis Health founded?

    Vocalis Health was founded in 2019.

  • Where is Vocalis Health's headquarters?

    Vocalis Health's headquarters is located at 275 Grove Street, Newton.

  • What is Vocalis Health's latest funding round?

    Vocalis Health's latest funding round is Incubator/Accelerator.

  • How much did Vocalis Health raise?

    Vocalis Health raised a total of $9M.

  • Who are the investors of Vocalis Health?

    Investors of Vocalis Health include Plug and Play Accelerator and aMoon Fund.

  • Who are Vocalis Health's competitors?

    Competitors of Vocalis Health include Aural Analytics and 5 more.

You May Also Like

Winterlight Labs Logo
Winterlight Labs

WinterLight Labs has developed a technology that aims to quickly and accurately quantify speech and language patterns. With this technology, the company aims to help detect and monitor cognitive and mental diseases such as dementia and Alzheimer's.

Ellipsis Health Logo
Ellipsis Health

Ellipsis Health develops an artificial intelligence-powered, speech-based platform that aims to quantify and manage depression and anxiety symptoms.

Sonde Health Logo
Sonde Health

Sonde Health is a digital medicine company that develops a voice-based technology with the potential to monitor and diagnose mental and physical health. Sonde's technology works by sensing and analyzing subtle changes in the voice to create a range of persistent brain, muscle, and respiratory health measurements that provide a more complete picture of health in just seconds.

Modality.AI Logo

Modality.AI detects health conditions using conversational AI. The company's platform analyzes the video of a user (recorded while the user interacts with an on-screen avatar) for facial movements and speech patterns to evaluate changes in neurological diseases which provides objective data to clinical drug trials.


Kintsugi offers a self-journaling app that uses machine learning and clinically-proven techniques to tackle daily stress, anxiety and depression.

Aural Analytics Logo
Aural Analytics

Aural Analytics uses speech to detect subtle but clinically meaningful changes in brain health. The platform is completely agnostic to disease, device, location and language and powers applications throughout the world. Aural Analytics was founded in 2015 and is based in Scottsdale, Arizona.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.